Homeostatic Tissue Responses in Skin Biopsies from NOMID Patients with Constitutive Overproduction of IL-1β

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Aubert, Pamela ^a   Suárez Fariñas, Mayte ^b   Mitsui, Hiroshi ^b   Johnson Huang, Leanne M ^b   Harden, Jamie Lynn ^b   Pierson, Katherine C ^b   Dolan, Joseph G ^a   Novitskaya, Inna ^b   Coats, Israel ^b   Estes, Jacob ^c   Cowen, Edward W ^d   Plass, Nicole ^a   Lee, Chyi Chia Richard ^d   Sun, Hong Wei ^a   Lowes, Michelle A ^b   Goldbach Mansky, Raphaela ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; CD163 ANTIGEN; DEFENSIN; DEFENSIN ALPHA1; DEFENSIN ALPHA3; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR; TRANSCRIPTOME; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CCL20 GENE; CD3+ T LYMPHOCYTE; CELL INFILTRATION; CINCA SYNDROME; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA MODIFICATION; ENZYME ACTIVATION; EPIGENETICS; FEMALE; HUMAN; HUMAN TISSUE; INTERLEUKIN 17A GENE; INTERLEUKIN 6 GENE; INTERLEUKIN 8 GENE; MALE; PATIENT ASSESSMENT; PROTEIN EXPRESSION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SKIN BIOPSY; TUMOR NECROSIS FACTOR GENE; UPREGULATION;

ADOLESCENT; ADULT; ANTIGENS, CD; BIOPSY; CASPASE 1; CHILD; CHILD, PRESCHOOL; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HLA-DR ANTIGENS; HOMEOSTASIS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; LANGERHANS CELLS; MACROPHAGES; MALE; MICRORNAS; NEUTROPHILS; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; SKIN; T-LYMPHOCYTES;

EID: 84870722327     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049408     Document Type: Article

References (51)

1. Masters SL, Simon A, Aksentijevich I, Kastner DL, (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 27: 621-668.
2. Saito M, Nishikomori R, Kambe N, Fujisawa A, Tanizaki H, et al. (2008) Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients. Blood 111: 2132-2141.
3. Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, et al. (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 355: 581-592.
4. Caroli F, Pontillo A, D'Osualdo A, Travan L, Ceccherini I, et al. (2007) Clinical and genetic characterization of Italian patients affected by CINCA syndrome. Rheumatology (Oxford) 46: 473-478.
5. Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, et al. (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71: 198-203.
6. Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, et al. (2002) De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 46: 3340-3348.
7. Sibley CH, Plass N, Snow J, Wiggs EA, Brewer CC, et al. (2012) Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes. Arthritis Rheum 64: 2375-2386.
8. Gattorno M, Tassi S, Carta S, Delfino L, Ferlito F, et al. (2007) Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum 56: 3138-3148.
9. Nakamura Y, Kambe N, Saito M, Nishikomiri R, Kim YG, et al. (2009) Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med 206: 1037-1046.
10. Leslie KS, Lachmann HJ, Bruning E, McGrath JA, Bybee A, et al. (2006) Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations. Arch Dermatol 142: 1591-1597.
11. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, et al. (1992) Molecular cloning of the interleukin-1 beta converting enzyme. Science 256: 97-100.
12. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768-774.
13. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, et al. (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364: 1779-1785.
14. Zaba LC, Fuentes-Duculan J, Steinman RM, Krueger JG, Lowes MA, (2007) Normal human dermis contains distinct populations of CD11cBDCA-1 dendritic cells and CD163FXIIIA macrophages. J Clin Invest 117: 2517-2525.
15. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, et al. (1997) Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386: 619-623.
16. Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, et al. (2002) Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18: 61-71.
17. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, et al. (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11: 1014-1022.
18. Suárez-Fariñas M, Lowes MA, Zaba LC, Krueger JG, (2010) Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA). PLoS One 5: e10247.
19. Gulen MF, Kang Z, Bulek K, Youzhong W, Kim TW, et al. (2010) The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity 32: 54-66.
20. Vandercappellen J, Van Damme J, Struyf S, (2008) The role of CXC chemokines and their receptors in cancer. Cancer Lett 267: 226-244.
21. Soehnlein O, Lindbom L, (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10: 427-439.
22. Scapini P, Laudanna C, Pinardi C, Allavena P, Mantovani A, et al. (2001) Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)/CCL20 and MIP-3beta/CCL19. Eur J Immunol 31: 1981-1988.
23. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, et al. (1999) CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 162: 186-194.
24. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
25. Kloetzel PM, (2001) Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2: 179-187.
26. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, et al. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105: 13027-13032.
27. Liao Y, Lonnerdal B, (2010) Global microRNA characterization reveals that miR-103 is involved in IGF-1 stimulated mouse intestinal cell proliferation. PLoS One 5: e12976.
28. Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, et al. (2007) MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2: e610.
29. Kuwata H, Watanabe Y, Miyoshi H, Yamamoto M, Kaisho T, et al. (2003) IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 102: 4123-4129.
30. Wessells J, Baer M, Young HA, Claudio E, Brown K, et al. (2004) BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem 279: 49995-50003.
31. Suárez-Fariñas M, Fuentes-Duculan J, Lowes MA, Krueger JG, (2010) Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol 131: 391-400.
32. Mantovani A, Cassatella MA, Costantini C, Jaillon S, (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11: 519-531.
33. Kumar V, Sharma A, (2010) Neutrophils: Cinderella of innate immune system. Int Immunopharmacol 10: 1325-1334.
34. Bazzoni F, Tamassia N, Rossato M, Cassatella MA, (2010) Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: lessons from neutrophils. Eur J Immunol 40: 2360-2368.
35. Miles K, Clarke DJ, Lu W, Sibinska Z, Beaumont PE, et al. (2009) Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J Immunol 183: 2122-2132.
36. Gasser O, Schifferli JA, (2004) Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 104: 2543-2548.
37. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, et al. (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
38. Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Suarez-Farinas M, et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159: 1086-1091.
39. Lopez Kostka S, Dinges S, Griewank K, Iwakura Y, Udey MC, et al. (2009) IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol 182: 3039-3046.
40. Meng G, Zhang F, Fuss I, Kitani A, Strober W, (2009) A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 30: 860-874.
41. Brydges SD, Mueller JL, McGeough MD, Pena CA, Misaghi A, et al. (2009) Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 30: 875-887.
42. Beeson PB, (1947) Tolerance to Bacterial Pyrogens: I. Factors Influencing Its Development. J Exp Med 86: 29-38.
43. West MA, Heagy W, (2002) Endotoxin tolerance: A review. Crit Care Med 30: S64-S73.
44. Cavaillon JM, Adib-Conquy M, (2006) Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 10: 233.
45. Saccani S, Pantano S, Natoli G, (2002) p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 3: 69-75.
46. Foster SL, Hargreaves DC, Medzhitov R, (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978.
47. Mantovani A, Locati M, Polentarutti N, Vecchi A, Garlanda C, (2004) Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR. J Leukoc Biol 75: 738-742.
48. Natoli G, Ghisletti S, Barozzi I, (2011) The genomic landscapes of inflammation. Genes Dev 25: 101-106.
49. Dinarello CA, (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519-550.
50. Hill SC, Namde M, Dwyer A, Poznanski A, Canna S, et al. (2007) Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA). Pediatr Radiol 37: 145-152.
51. Fuentes-Duculan J, Suárez-Fariñas M, Zaba LC, Nograles KE, Pierson KC, et al. (2010) A subpopulation of CD163-positive macrophages is classically activated in psoriasis. J Invest Dermatol 130: 2412-2422.